Publication | Closed Access

A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients

Hematological MalignancyChromatinImatinib Mesylate-induced ThrombocytopeniaMedicineGeneticsGenetic EpidemiologyImmunologyHematologyTrough Level ConcentrationOct1 Genetic PolymorphismsMolecular DiagnosticsImmune-related Gene PolymorphismMyeloid Neoplasia